Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 1998

View Archived Issues

Tin complexes with antitumor activity disclosed by Pharmachemie

Antitumor agents isolated from Streptomyces by Japanese lab

Future antiglaucoma drug candidates added to the pipeline at Alcon

Potential cardiovascular agents act by increasing HDL cholesterol

MRI contrast agents reported by Hoechst Celanese

MDL-103294 and related antioxidants described by Hoechst Marion Roussel

Novel cysteine protease inhibitors discussed by BASF

Company Profile: Arachnova

Wound-healing asiatic acid derivatives under investigation at Dong Kook

Antimuscarinic agent KRP-197 shows potential for treating incontinence

Thymosin alpha 1 receives patent protection for hepatitis C indication

New indication approved for AmBisome in the U.K.

Corvas and Schering-Plough discontinue collaboration; other projects remain on track

Phytera and Tsumura Juntendo expand research collaboration

Access licensee files for U.K. approval of amlexanox oral paste

Fungal enzyme inhibitors synthesized at Nippon Roche

GeneMedicine reports progress in its development of dendritic cell-based genetic vaccines

EU approval granted for Novo's orally active antidiabetic agent NovoNorm

First European filing for TOBI

Antiinvasive activity demonstrated with Servier's zinc chelator/MMP inhibitor

Fluoroquinolone antibacterial available for licensing from Dong Wha

Imutec receives patent protection for Virulizin in Canada

Strategy to improve the bioavailability of anthelmintic agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026